Holen Sie sich die Stockscreener-App
689.35
1.11%
-7.75
Handel nachbörslich:
692.50
3.15
+0.46%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$697.10
Offen:
$697.82
24-Stunden-Volumen:
767.52K
Relative Volume:
1.63
Marktkapitalisierung:
$55.15B
Einnahmen:
$4.17B
Nettoeinkommen (Verlust:
$1.03B
KGV:
54.65
EPS:
12.6148
Netto-Cashflow:
$940.22M
1W Leistung:
-1.73%
1M Leistung:
+7.14%
6M Leistung:
+33.30%
1J Leistung:
+64.68%
1-Tages-Spanne:
$688.48
$710.72
1-Wochen-Bereich:
$665.25
$710.72
52-Wochen-Spanne:
$356.14
$735.00
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Vergleichen Sie IDXX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
689.35 | 55.66B | 4.17B | 1.03B | 940.22M | 12.61 |
|
TMO
Thermo Fisher Scientific Inc
|
572.74 | 215.58B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
222.18 | 157.10B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
A
Agilent Technologies Inc
|
145.06 | 40.94B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
217.11 | 37.04B | 15.90B | 1.28B | 2.21B | 7.2842 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-31 | Hochstufung | Stifel | Hold → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-08-05 | Bestätigt | BTIG Research | Buy |
| 2025-07-01 | Eingeleitet | Jefferies | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
Idexx Laboratories (IDXX) Recently Broke Out Above the 20-Day Moving Average - Yahoo Finance
Will IDEXX Laboratories Inc. stock outperform growth indexes2025 Top Gainers & Technical Pattern Based Signals - newser.com
Why IDEXX Laboratories Inc. stock could benefit from AI revolutionWeekly Volume Report & Entry Point Confirmation Signals - newser.com
How robust is IDEXX Laboratories Inc. (IX1) stock financial positionWeekly Stock Report & AI Forecasted Entry/Exit Points - newser.com
Can IDEXX Laboratories Inc. (IX1) stock retain market dominanceQuarterly Profit Review & Short-Term High Return Strategies - newser.com
Why IDEXX Laboratories Inc. stock is a must watch in 2025Portfolio Risk Report & Intraday High Probability Alerts - newser.com
Why IDEXX Laboratories Inc. (IX1) stock stays undervaluedTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
Quantitative breakdown of IDEXX Laboratories Inc. recent moveTrade Risk Assessment & Precise Entry and Exit Recommendations - newser.com
Is IDEXX Laboratories Inc. stock cheap at current valuationEntry Point & Community Verified Trade Signals - newser.com
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
Is IDEXX Laboratories Inc. stock attractive for ETFs2025 Institutional Moves & Weekly Breakout Watchlists - newser.com
Best Manufacturing: IDEXX Horizon Center - Engineering News-Record | ENR
Does IDEXX Laboratories Inc. fit your quant trading modelWeekly Stock Report & Risk Controlled Swing Alerts - newser.com
Why retail investors favor IDEXX Laboratories Inc. stockWeekly Gains Report & Fast Exit Strategy with Risk Control - newser.com
William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating - 富途牛牛
Is IDEXX Laboratories Inc. stock trading at a premium valuation2025 Price Targets & Low Drawdown Investment Strategies - newser.com
IDEXX Laboratories (IDXX) Price Target Increased by 10.84% to 773.18 - Nasdaq
What machine learning models say about IDEXX Laboratories Inc.Rate Hike & Fast Entry Momentum Trade Alerts - newser.com
Is IDEXX Laboratories Inc. stock supported by strong cash flows - newser.com
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.46%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):